A preparation method of high-purity streptomycin sulfate

By using technical means such as composite coagulant and medium polar organic solvent, the streptomycin extraction process is simplified, the problems of low production efficiency, high cost and difficult impurity removal in the existing technology are solved, and high purity streptomyces sulfate are achieved The efficient preparation of proteins has significantly improved the purity and traits of the product.

CN118724989BActive Publication Date: 2024-12-03INNER MONGOLIA SHENGXUE DACHENG PHARM CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411216844.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-09-02
Publication Date
2024-12-03
Estimated Expiration
2044-09-02

AI Technical Summary

Technical Problem

The existing streptomycin extraction and purification process has low production efficiency, high cost and low yield, and cannot effectively remove impurities with similar structure to streptomycin, resulting in low titers for the final product and excessive substances.

Method used

Filtration was performed by stirring and filtering with composite coagulant (magnesium chloride-polydimethyldiallyl ammonium chloride and diatomaceous earth), then sodium bisulfite and medium polar organic solvent were added for reaction and layered recovery, followed by thin film Concentration and activated carbon treatment, followed by desalting and removal of endotoxins through nanofiltration membrane and ultrafiltration membrane, and finally obtained high-purity streptomycin sulfate by drying.

Benefits of technology

It greatly reduces the cost of production materials and time, removes impurities similar to streptomycin structure, improves product purity and traits, simplifies operations, and reduces wastewater and energy consumption.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118724989B_ABST
    Figure CN118724989B_ABST
Patent Text Reader

Abstract

The present invention relates to the field of medicine, and specifically to a method for preparing high-purity streptomycin sulfate, comprising the following steps: S1, adding a composite coagulant to a streptomycin fermentation broth for stirring, filtering, and removing precipitated impurities. The traditional streptomycin sulfate purification process is through two ion exchange columns, multiple adsorption, desorption, and column regeneration, which is time-consuming, requires a large amount of acid water, and the product has a low concentration in the eluent, and requires a large amount of energy for concentration. Not only is the route long, the production efficiency is low, the cost is high, and the properties of the finished product are often unqualified. The preparation method provided by the present invention uses sodium bisulfite to form an adduct with streptomycin in the fermentation broth, and the adduct can form crystals and precipitate, so that the product is separated from organic impurities, and then sulfuric acid is used to acidify the adduct, and at the same time, it is salified with streptomycin, and then inorganic impurities are removed to obtain high-purity streptomycin sulfate, and the product purity can reach 99.7%, and the production cost is reduced by about one-half.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of medicine, and in particular to a method for preparing high-purity streptomycin sulfate. Background Art

[0002] Antibiotics, also known as antimicrobials, are a class of secondary metabolites produced by microorganisms (including bacteria, fungi, and actinomycetes) or higher animals and plants in their life activities that have anti-pathogen or other activities, and are chemical substances that can interfere with the developmental functions of other cells. Commonly used antibiotics in clinical practice include extracts from microbial culture fluids and chemically synthesized or semi-synthesized compounds. Currently, penicillins, cephalosporins, aminoglycosides, tetracyclines, macrolides, aminoglycosides, lincomycins, etc. are commonly used.

[0003] Streptomycin is an aminoglycoside antibiotic with the chemical name O-2-methylamino-2-deoxy-ɑ-L-glucopyranosyl-(1→2)-O-5-deoxy-3-C-formyl-ɑ-L-lyxofuranosyl-(1→4)-N 1 ,N 3 -diamidino-D-streptamine sulfate is a white or off-white powder. In 1943, Selman A. Waksman, a Ph.D. from the University of California, Berkeley and a professor at Rutgers University, isolated it from Streptomyces. It was the second antibiotic produced and used clinically after penicillin. Waksman won the 1952 Nobel Prize for this. The clinical dosage form of streptomycin is an injection. Its mechanism of action is to interfere with bacterial protein synthesis. It is indicated for use in combination with other anti-tuberculosis drugs for the initial treatment of various tuberculosis cases caused by Mycobacterium tuberculosis, or other sensitive Mycobacterium infections; it can be used alone to treat tularemia, or in combination with other antibacterial drugs for the treatment of plague, granuloma inguinale, brucellosis, rat-bite fever, etc.; it can also be combined with penicillin or ampicillin to treat endocarditis caused by viridans streptococci or enterococci. Its chemical structure is as follows: Figure 1 shown.

[0004] Streptomycin is produced by fermentation of Streptomyces griseus, and then artificially extracted and purified to obtain pharmaceutical raw materials. At present, there are literature reports on the fermentation and extraction methods of streptomycin. The extremely high purity requirements of traditional fermentation processes for producing antibiotic products pose serious challenges to the purification process. Since the growth process of microorganisms requires many kinds of nutrients, and with the progress of life activities, a large number of metabolites are also produced. Antibiotics are only one of their metabolites. Compared with the chemical synthesis method, its concentration in the fermentation broth is not very large. Therefore, the purification of fermentation raw materials has always been one of the research hotspots. The processes between different manufacturers sometimes have a large gap in cost and product quality. Streptomycin extraction mainly includes acidification of streptomycin fermentation broth, membrane filtration, dynamic adsorption of ion exchange resin, desorption of sulfuric acid aqueous solution, primary desorption liquid adsorption by resin, desorption of sulfuric acid aqueous solution, desalting and neutralization of secondary desorption liquid by resin bed, decolorization, thin film concentration, ultrafiltration, spray drying and other processes. Along with a large number of purification process steps, it is inevitable to use a large amount of acid and alkali substances, produce a large amount of wastewater and waste residue, and the energy consumption is also high. Therefore, every improvement in the purification process is a revolution in environmental protection and cost.

[0005] The streptomycin extraction and purification process disclosed in the prior art includes the following steps: ① first, the fermentation liquid is acidified with a large amount of acid; ② then adsorbed and desorbed by ion exchange resin; ③ macroporous resin adsorption and desorption to obtain streptomycin solution; ④ secondary desorption liquid is desalted and neutralized by a mixed bed composed of resins; ⑤ medicinal activated carbon decolorization; ⑥ film concentration, ultrafiltration, removal of endotoxins and pigments; ⑦ spray drying to obtain the finished streptomycin sulfate; the above process only removes organic impurities, metabolites and inorganic salts that are significantly different from streptomycin structures, but cannot remove metabolic byproducts similar to streptomycin structures, thus resulting in low potency of the final finished product and excessive related substances. In addition, this purification process undergoes two ion exchanges, which is very time-consuming in actual production, requiring multiple column loading, washing and activating the exchange column, elution with a large amount of acid water, and detection. After the exchange column is used, a large amount of time and solvent are required for resin regeneration. The product has a low concentration in the eluent and needs to consume a large amount of energy for concentration. Not only is the line long, the production efficiency is low, the cost is high, and the yield is low, but the properties of the purified streptomycin sulfate product are often unqualified. Summary of the invention

[0006] The purpose of the present invention is to provide a method for preparing high-purity streptomycin sulfate to solve the problems of low production efficiency, high cost and low yield in the existing streptomycin extraction and purification process.

[0007] In order to solve the above technical problems, the present invention provides a method for preparing high-purity streptomycin sulfate, comprising the following steps:

[0008] S1, adding a composite coagulant to the streptomycin fermentation broth and stirring, filtering to obtain solution 1, and removing precipitated impurities, wherein the composite coagulant is magnesium chloride-polydimethyldiallylammonium chloride and diatomaceous earth, and the mass ratio of the composite coagulant to the fermentation broth is 4-6:1000;

[0009] S2, adding sodium bisulfite to the solution 1 prepared in step S1, stirring and reacting completely, adding a medium polar organic solvent, stirring for 30 minutes, and after layering, recovering the organic phase, collecting the aqueous phase to obtain a solution 2, wherein the mass ratio of sodium bisulfite to streptomycin in the filtrate 1 is 1-6:6, the medium polar organic solvent is one of ethyl acetate and dichloromethane, and the mass ratio of the medium polar organic solvent to the solution 1 is 1-6:2;

[0010] S3, the solution 2 prepared in step S2 is concentrated by thin film until solid precipitates out, the concentration is stopped, the concentrated solution is cooled and stirred for crystallization for 3-5 hours, and after filtering, the filter cake is washed with pre-cooled purified water to obtain solid 1;

[0011] S4, adding the solid 1 prepared in step S3, medicinal activated carbon, and purified water into a reactor, stirring for 0.5-1h, filtering, and dropping a dilute sulfuric acid solution into the filtrate to obtain a solution 3 with a pH of 2-4, wherein the weight ratio of the solid 1, medicinal activated carbon, and purified water is 100:3:300-500;

[0012] S5, performing a nanofiltration desalination on the solution 3 prepared in step S4 using a nanofiltration membrane, and then performing a secondary ultrafiltration to remove bacterial endotoxins and pyrogens, to obtain a solution 4;

[0013] S6. Drying the solution 4 prepared in step S5 to obtain high-purity streptomycin sulfate.

[0014] Furthermore, in step S1, the mass ratio of the composite coagulant aid magnesium chloride-polydimethyldiallylammonium chloride to diatomaceous earth is 2:1.

[0015] Furthermore, the solid 1 in step S3 is an adduct of streptomycin and sodium bisulfite, and its structural formula is:

[0016]

[0017] Furthermore, the concentration of the dilute sulfuric acid in step S4 is 10-50%.

[0018] Furthermore, the pore size of the nanofiltration membrane used for the primary desalination in step S5 is 200 molecular weight, and the pore size of the secondary ultrafiltration membrane is 5000 molecular weight.

[0019] Furthermore, the drying method in step S6 is one of fluidized bed drying and spray drying.

[0020] The beneficial effect of the preparation method of a high-purity streptomycin sulfate provided by the present invention is as follows: compared with the existing streptomycin extraction and purification process, the preparation method of streptomycin sulfate disclosed in the present invention does not need to pass through the resin column twice, which greatly reduces the production material cost, time cost, and material cost. More importantly, the technical solution provided by this scheme can remove impurities similar to the streptomycin structure, such as tobramycin, dihydrostreptomycin, and impurities at a relative retention time of 0.9 recorded in the 2020 edition of the Chinese Pharmacopoeia. Compared with the existing technology, it has the advantages of simple operation, greatly reduced cost, reduced wastewater and energy consumption, and greatly improved product properties and purity. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 The chemical structure of streptomycin.

[0022] Figure 2 Process flow chart.

[0023] Figure 3 HPLC spectrum of streptomycin sulfate prepared in Example 2. DETAILED DESCRIPTION

[0024] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0025] Embodiment 1:

[0026] Add 80kg of streptomycin fermentation liquid to a 200L reactor, detect the concentration in the liquid phase, and calculate that it contains 2.03kg of streptomycin. Add 0.2kg of magnesium chloride-polydimethyldiallylammonium chloride and 0.1kg of diatomaceous earth, stir for 2h, filter, remove the precipitate, and collect the filtrate. Add 0.33kg of sodium bisulfite to the filtrate, stir and react for 1h, add 40kg of dichloromethane, stir for 30min, separate, recover dichloromethane, collect the aqueous phase, concentrate the aqueous phase through a thin film until solid precipitation stops, then cool to 3°C, stir and crystallize for 3h, filter, and wash the filter cake with 0.2kg of pre-cooled purified water to obtain a solid sample. Add the washed solid sample to a 50L reactor, then add 3 times the weight ratio of purified water and 0.03 times the weight ratio of medicinal activated carbon to the solid sample, stir for 0.5h, filter, and drop 10% dilute sulfuric acid solution into the filtered filtrate until the pH of the system is 2 to obtain an acid hydrolysis solution. The acid hydrolysis solution is desalted using a 200 molecular weight nanofiltration membrane, and then an ultrafiltration membrane with a 5000 molecular weight is used to remove endotoxins and pyrogens. The solution after ultrafiltration is spray-dried to obtain a white streptomycin sulfate product.

[0027] Embodiment 2:

[0028] Add 80kg of streptomycin fermentation liquid to a 200L reactor, detect the concentration in the liquid phase, and calculate that it contains 2.03kg of streptomycin. Add 0.32kg of magnesium chloride-polydimethyldiallyl ammonium chloride and 0.16kg of diatomaceous earth, stir for 2h, filter, remove the precipitate, and collect the filtrate. Add 1.98kg of sodium bisulfite to the filtrate, stir and react for 1h, add 240kg of dichloromethane, stir for 30min, separate, recover dichloromethane, collect the aqueous phase, concentrate the aqueous phase through a thin film until solid precipitation stops, then cool to 3°C, stir and crystallize for 3h, filter, and wash the filter cake with 0.2kg of pre-cooled purified water to obtain a solid sample. Add the above solid sample to a 50L reactor, then add 5 times the weight ratio of purified water and 0.03 times the weight ratio of medicinal activated carbon to the solid sample, stir for 0.5h, filter, and drop 50% dilute sulfuric acid solution into the filtrate until the pH of the system is 2 to obtain an acid hydrolysis solution. The acid hydrolysis solution is desalted using a 200 molecular weight nanofiltration membrane, and then an ultrafiltration membrane with a 5000 molecular weight is used to remove endotoxins and pyrogens. The ultrafiltration treated solution is spray dried to obtain a white streptomycin sulfate finished product.

[0029] Embodiment 3:

[0030] Add 80kg of streptomycin fermentation liquid to a 200L reactor, detect the concentration in the liquid phase, and calculate that it contains 2.03kg of streptomycin. Add 0.32kg of magnesium chloride-polydimethyldiallylammonium chloride and 0.16kg of diatomaceous earth, stir for 2h, filter, remove the precipitate, and collect the filtrate. Add 1.98kg of sodium bisulfite to the filtrate, stir and react for 1h, add 240kg of ethyl acetate, stir for 30min, separate the layers, recover the ethyl acetate, and collect the aqueous phase. The aqueous phase is concentrated by thin film until solid precipitation stops, then cooled to 3°C, stirred and crystallized for 3h, filtered, and the filter cake is washed with 0.2kg of pre-cooled purified water to obtain a solid sample. Add the above solid sample to a 50L reactor, then add 5 times the weight ratio of purified water and 0.03 times the weight ratio of medicinal activated carbon to the solid sample, stir for 0.5h, filter, and drop 50% dilute sulfuric acid solution into the filtrate until the pH of the system is 2. The acid hydrolysis solution is desalted using a 200 molecular weight nanofiltration membrane, and then an ultrafiltration membrane with a 5000 molecular weight is used to remove endotoxins and pyrogens. The ultrafiltration treated solution is spray dried to obtain a white streptomycin sulfate finished product.

[0031] Embodiment 4:

[0032] Add 80kg of streptomycin fermentation liquid to a 200L reactor, detect the concentration in the liquid phase, and calculate that it contains 2.03kg of streptomycin. Add 0.32kg of magnesium chloride-polydimethyldiallylammonium chloride and 0.16kg of diatomaceous earth, stir for 2h, filter, remove the precipitate, and collect the filtrate. Add 1.98kg of sodium bisulfite to the filtrate, stir and react for 1h, add 240kg of dichloromethane, stir for 30min, separate into layers, recover dichloromethane, and collect the aqueous phase. The aqueous phase is concentrated by thin film until solid precipitation stops, then cooled to 3°C, stirred and crystallized for 3h, filtered, and the filter cake is washed with 0.2kg of pre-cooled purified water to obtain a solid sample. Add the above solid sample to a 50L reactor, then add 5 times the weight ratio of purified water and 0.03 times the weight ratio of medicinal activated carbon to the solid sample, stir for 0.5h, filter, and drop 50% dilute sulfuric acid solution into the filtrate until the pH of the system is 2 to obtain an acid hydrolysis solution. The acid hydrolysis solution is desalted using a 200 molecular weight nanofiltration membrane, and then an ultrafiltration membrane with a 5000 molecular weight is used to remove endotoxins and pyrogens. The ultrafiltration treated solution is dried in a fluidized bed to obtain a white streptomycin sulfate product.

[0033] Comparative Example 1:

[0034] Add 80kg of streptomycin fermentation liquid to a 200L reactor, add oxalic acid solution to adjust the system pH to 2-4, heat to 60℃, stir for 1h, filter to remove precipitated impurities, and collect the filtrate. The filtrate is adjusted to neutral pH with 18% sodium hydroxide solution, and then saturated with sodium type 110 resin, washed with purified water. After washing, squeeze the purified water in the resin column, and then elute with 4.5% dilute sulfuric acid to obtain streptomycin sulfate eluate. After the streptomycin eluate is saturated with macroporous primary amino resin D318, it is washed with purified water and then eluted with 6.5% dilute sulfuric acid solution until there is no streptomycin sulfate in the filtrate. The desorption liquid is neutralized by mixed bed desalting composed of 1×25 resin and 703 resin in a mass ratio of 1:1 to obtain a refined liquid. Add 500g of medicinal activated carbon to the refined liquid and stir for 1h to decolorize. Filter and concentrate the filtrate with a 200 molecular weight nanofiltration membrane. The bacterial endotoxin and pyrogen were removed by ultrafiltration membrane with molecular weight of 6000. The ultrafiltrate was spray-dried to obtain off-white streptomycin sulfate.

[0035] The test results are shown in the following table:

[0036] Example Example 1 Example 2 Example 3 Example 4 Comparative Example 1 Finished product yield 56.2% 90.5% 91.7% 86.5% 89.1% Finished product properties White solid White solid White solid White solid Off-white solid Drying method Spray drying Spray drying Spray drying Fluidized bed drying Spray drying Purity of finished product 99.7% 99.6% 99.1% 99.6% 96.3% Production cycle 5 days 5 days 5 days 6 days 9 days

[0037] Test results: The finished products of streptomycin sulfate prepared in Examples 1-4 are all white solids, which are significantly better than the off-white solid of Comparative Example 1; the purity of the finished products of Examples 1-4 is significantly better than that of Comparative Example 1, among which the purity of Example 2 is better than that of Example 3, indicating that dichloromethane is better than ethyl acetate as a washing solvent; the production cycles of Examples 1-3 are significantly shortened compared with Comparative Example 1, and the cost is almost reduced by half.

Claims

1. A method for preparing high-purity streptomycin sulfate, characterized in that: The following steps are involved: S1, adding a composite coagulant to the streptomycin fermentation broth and stirring, filtering to obtain solution 1, and removing precipitated impurities, wherein the composite coagulant is magnesium chloride-polydimethyldiallylammonium chloride and diatomaceous earth, and the mass ratio of the composite coagulant to the fermentation broth is 4-6:1000; S2, adding sodium bisulfite to the solution 1 prepared in step S1, stirring and reacting completely, adding a medium polar organic solvent, stirring for 30 minutes, and after layering, recovering the organic phase, collecting the aqueous phase to obtain a solution 2, wherein the mass ratio of sodium bisulfite to the streptomycin in the solution 1 is 1-6:6, the medium polar organic solvent is one of ethyl acetate and dichloromethane, and the mass ratio of the medium polar organic solvent to the solution 1 is 1-6:2; S3, the solution 2 prepared in step S2 is concentrated by thin film until solid precipitates out, the concentration is stopped, the concentrated solution is cooled and stirred for crystallization for 3-5 hours, and after filtering, the filter cake is washed with pre-cooled purified water to obtain solid 1; S4, adding the solid 1 prepared in step S3, medicinal activated carbon, and purified water into a reactor, stirring for 0.5-1h, filtering, and dropping a dilute sulfuric acid solution into the filtrate to obtain a solution 3 with a pH of 2-4, wherein the weight ratio of the solid 1, medicinal activated carbon, and purified water is 100:3:300-500; S5, performing a nanofiltration desalination on the solution 3 prepared in step S4 using a nanofiltration membrane, and then performing a secondary ultrafiltration to remove bacterial endotoxins and pyrogens, to obtain a solution 4; S6. Drying the solution 4 prepared in step S5 to obtain high-purity streptomycin sulfate.

2. The method for preparing high-purity streptomycin sulfate according to claim 1, characterized in that: The mass ratio of magnesium chloride-polydimethyldiallylammonium chloride to diatomaceous earth in the composite coagulant in step S1 is 2:

1.

3. The method for preparing high-purity streptomycin sulfate according to claim 1, characterized in that: The solid 1 in step S3 is an adduct of streptomycin and sodium bisulfite, and its structural formula is: 。 4. The method for preparing high-purity streptomycin sulfate according to claim 1, characterized in that: The concentration of dilute sulfuric acid in step S4 is 10-50%.

5. The method for preparing high-purity streptomycin sulfate according to claim 1, characterized in that: The pore size of the nanofiltration membrane used for the primary desalination in step S5 is 200 molecular weight, and the pore size of the secondary ultrafiltration membrane is 5000 molecular weight.

6. The method for preparing high-purity streptomycin sulfate according to claim 1, characterized in that: The drying method in step S6 is one of fluidized bed drying and spray drying.

Citation Information

Patent Citations

  • Extraction method of streptomycin sulfate

    CN105524130A

  • Extraction and preparation method of streptomycin sulfate

    CN106349305A